Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MiniMed Group Inc. Common Stock (MMED) vs Raytheon Technologies Corp (RTX) Price & Performance

MiniMed Group Inc. Common StockTrade
Raytheon Technologies CorpTrade

Price performance (Past 24H)

Key statistics

MiniMed Group Inc. Common Stock vs Raytheon Technologies Corp — how do they compare? MiniMed Group Inc. Common Stock trades at $19.57 (market cap $5.57B), while Raytheon Technologies Corp trades at $184.71 (market cap $248.42B). The key difference: Raytheon Technologies Corp is far larger — about 44.6× MiniMed Group Inc. Common Stock's market cap, and Raytheon Technologies Corp pays a 1.58% dividend while MiniMed Group Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MiniMed Group Inc. Common Stock for 0 Days and Raytheon Technologies Corp for 78 Days on average.

MMEDRTX
Market Cap
$5.57B$248.42B
Volume
23,336,0734,380,368
Sector
HealthIndustrials
52-Week High
$23.84$225.49
52-Week Low
$10.80$157.00
Typical Hold Time
0 Days78 Days
Enterprise Value
$5.37B$278.97B
Dividend Yield
—1.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MiniMed Group Inc. Common Stock

No Aura AI signal available yet.

Raytheon Technologies Corp

RTX trades at $180.26, down 1.65% today, amid a bearish technical signal but strong fundamental performance. The company reported three consecutive quarterly earnings beats, with Q3 2026 EPS expected at $1.77. Revenue grew to $88.6B in 2025, with net income margin improving to 7.59%. Analyst consensus remains strongly bullish with a $236.27 price target and 65% buy ratings, supported by a $289B backlog and defense sector tailwinds.

The outlook for RTX is positive given robust defense spending, earnings momentum, and analyst confidence. Risks include execution on large contracts, debt levels, and geopolitical uncertainties. The stock offers growth potential with a 30% upside to consensus target, but investors should monitor quarterly execution and defense budget developments.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MMED
100% Buy0% Sell
Avg holding period · 0 Days
RTX
100% Buy0% Sell
Avg holding period · 78 Days

Top news

Latest headlines on both assets

About MiniMed Group Inc. Common Stock

MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.

Read more on MMED →

About Raytheon Technologies Corp

Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.

Read more on RTX →